Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 40.60
+0.64 (1.60%)
Apr 30, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 27.54 billion as of April 30, 2026. Its market cap has increased by 29.73% in one year.
Market Cap
27.54B
Enterprise Value
23.28B
Revenue
4.92B
Ranking
n/a
PE Ratio
14.66
Stock Price
40.60
Market Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 27.54B, an increase of 298.19%. That is a compound annual growth rate of 5.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 27.17B | -11.72% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humanwell Healthcare (Group) | 30.34B |
| Shijiazhuang Yiling Pharmaceutical | 28.00B |
| Livzon Pharmaceutical Group | 26.50B |
| Dizal (Jiangsu) Pharmaceutical | 26.14B |
| Hubei Jumpcan Pharmaceutical | 24.59B |
| Kangmei Pharmaceutical | 23.65B |
| Zhejiang Huahai Pharmaceutical | 23.52B |
| Chengdu Kanghong Pharmaceutical Group | 23.31B |